Park S J, Pifarre R, Sullivan H, Montoya A, Kim S Y
Loyola University Medical Center, Department of Thoracic and Cardiovascular Surgery, Maywood, IL 60153, USA.
Cardiovasc Surg. 1996 Feb;4(1):37-41. doi: 10.1016/0967-2109(96)83781-1.
A total of 288 patients underwent heart transplantation at Loyola University Medical Center over a 8 1/2-year period starting in March, 1984. Of these patients, 54 were identified as having allograft coronary arteriopathy. Diagnosis was made on the basis of abnormal findings on coronary angiography in 44 patients; either an autopsy or explanted heart revealed the diagnosis in the remainder. A total of 279 abnormal lesions were identified by coronary angiography, and over 70% of these stenoses were discrete and located in large epicardial vessels. The left ventricular ed-diastolic pressure demonstrated a steady rise over time (2.5 mmHg/year), and also correlated with the degree of allograft coronary arteriopathy stenosis. The rate of stenosis progression was 33% per year from the time of initial allograft coronary arteriopathy development. Actuarial survival rate was lower than that of patients with arteriopathy. In conclusion, first, the majority of allograft coronary arteriopathy stenoses detected on coronary angiography are discrete, involve large epicardial vessels, and progress rapidly over time. Second, left ventricular end-diastolic pressure seems to reflect the degree of allograft coronary arteriopathy stenosis, and may prove to be a useful indicator of left ventricular dysfunction related to allograft coronary arteriopathy. Third, patients with allograft coronary arteriopathy show a decreased actuarial survival rate.
从1984年3月开始的8年半时间里,共有288例患者在洛约拉大学医学中心接受了心脏移植。在这些患者中,54例被确诊患有移植心脏冠状动脉病变。44例患者根据冠状动脉造影的异常结果确诊;其余患者通过尸检或取出的心脏确诊。冠状动脉造影共发现279处异常病变,其中70%以上的狭窄为局限性,位于大的心外膜血管。左心室舒张末期压力随时间稳步上升(每年2.5 mmHg),且与移植心脏冠状动脉病变狭窄程度相关。从移植心脏冠状动脉病变最初发生时起,狭窄进展率为每年33%。精算生存率低于无病变患者。总之,第一,冠状动脉造影检测到的大多数移植心脏冠状动脉病变狭窄为局限性,累及大的心外膜血管,且随时间迅速进展。第二,左心室舒张末期压力似乎反映了移植心脏冠状动脉病变狭窄程度,可能被证明是与移植心脏冠状动脉病变相关的左心室功能障碍的有用指标。第三,移植心脏冠状动脉病变患者的精算生存率降低。